Ultragenyx Pharmaceutical
Robyn Hylind, MS, CGC, currently serves as a Patient Diagnostic Liaison at Ultragenyx since January 2024. Previously, Robyn held positions at Boston Children's Hospital from April 2016 to January 2024, starting as a Cardiovascular Genetic Counselor and advancing to Senior Cardiac Genetic Counselor. Additional experience includes working as an International Client Services Specialist at Veracyte, Inc. from August 2012 to July 2014, and as a Clinical Research Assistant at Cepheid from February 2012 to August 2012. Robyn began professional pursuits as a Genetic Counseling Intern at Stanford University Medical Center in August 2011. Academically, Robyn earned a Master’s Degree in Genetic Counseling/Counselor from Northwestern University - The Feinberg School of Medicine and a Bachelor of Science in Molecular Biology from Santa Clara University.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.